SCHEMBL533055

SCHEMBL533055

Cc1cc(C)c(N2CCCC2)c(C)c1NS(=O)(=O)c1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
MAPT P10636 2/20 0.45
ADRA1A P35348 2/20 0.45
CYP3A4 P08684 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
RECQL P46063 1/20 0.43
HTR6 P50406 1/20 0.43
FFAR4 Q5NUL3 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
EDNRA P25101 2/20 0.41
PDE4A P27815 1/20 0.41
AGO2 Q9UKV8 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
EDNRB P24530 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 1/20 0.40
TERT O14746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL533017 0.90 FFAR4 (0.55) ALDH1A1MAPTSMN1; SMN2TDP1RECQL
SCHEMBL534816 0.88 MAPT (0.41) ALDH1A1MAPTSMN1; SMN2RECQLHTR6
SCHEMBL533437 0.87 CYTH2 (0.49) ALDH1A1MAPTSMN1; SMN2TDP1RECQL
SCHEMBL532880 0.87 FFAR4 (0.56) ALDH1A1MAPTSMN1; SMN2TDP1RECQL
SCHEMBL533666 0.87 FFAR4 (0.56) ALDH1A1MAPTRECQLFFAR4MEN1
SCHEMBL532776 0.87 FFAR4 (0.54) ALDH1A1MAPTCYP3A4TDP1RECQL
SCHEMBL533123 0.86 FFAR4 (0.42) ALDH1A1MAPTSMN1; SMN2TDP1RECQL
SCHEMBL534044 0.85 MAPT (0.43) ALDH1A1MAPTSMN1; SMN2TDP1RECQL
SCHEMBL533091 0.85 BRPF1 (0.52) ALDH1A1MAPTCYP3A4RECQLMEN1
SCHEMBL532953 0.85 FFAR4 (0.59) ALDH1A1MAPTSMN1; SMN2FFAR4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed